Events Partner Content Interstitial Lung Disease (ILD) Drug Development Summit Industry Led Conference on Fibrosing ILDs
News BMS swoops on Forbius, snaring another immuno-oncology playe... With the ink barely dry on a deal to develop Dragonfly’s lead cancer immunotherapy, Bristol-Myers Squibb’s business development team has agreed to buy Canadian biotech Forbius
Views & Analysis The promising future of RNA RNA technology-based therapeutics are a new and novel way to treat diseases.
News BMS begins Harvard fibrosis stem cell research collaboration R&D link-up with Harvard Fibrosis Network
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
